Serial Number | 87146623 |
Word Mark | REXADEV |
Filing Date | Monday, August 22, 2016 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Monday, September 7, 2020 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, June 6, 2017 |
Goods and Services | pharmaceutical preparations, biosimilars and pharmaceutical substances used for the treatment of bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, blood cells, blood vessel, and blood diseases and disorders; pharmaceutical preparations, biosimilars and pharmaceutical substances for the treatment of autoimmune, immune system, inflammatory, inflammatory bowel, gastrointestinal, genitourinary, musculoskeletal, dermatological, pulmonary, respiratory, oncological, hepatological, lymphomas, leukemias, ophthalmic, transplant rejection, cardiovascular, endocrine, neurological, sleep, muscular, and psychiatric diseases and disorders; pharmaceutical preparations and biosimilars, namely, pharmaceutical preparations and pharmaceutical substances used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, polymyalgia rheumatic, spondyloarthropathies, acute disc prolapse, inflammatory bowel disease, Crohn's disease, ulcerative colitis, Intestinal Behçet's Disease, chronic pouchitis, small bowel lesions, Hermansky-Pudlak syndrome, autoimmune pancreatitis, multiple myeloma, multiple sclerosis, systemic lupus erythematosus, lupus nephritis, chronic inflammatory demyelinating polyneuropathy, autoimmune anemia, autoimmune hemolytic anemia, pure red cell aplasia, idiopathic thrombocytopenic purpura, Evans syndrome, type 1 diabetes mellitus, Sjogren's syndrome, encephalitis, IgG4-related disease, Devic's disease, myositis, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, palmoplantar psoriasis, hidradenitis suppurativa, bullous skin disorder, pemphigus, pemphigoid, kawasaki disease, interstitial cystitis, sleep apnea, sarcoidosis, retinal vascular disorders, age-related macular degeneration, refractory diabetic macular edema, uveitis, childhood uveitis, uveitic macular edema, choroidal neovascularization, Graves' ophthalmopathy, pyoderma gangrenosum, giant cell arteritis, Netherton syndrome, anaplastic thyroid cancer, breast cancer, ovarian cancer, cervical cancer, gastric cancer, colorectal cancer, non-squamous non-small cell lung cancer, glioblastoma, renal cell carcinoma, head and neck cancer, Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, lymphocyte predominant subtype of Hodgkin's Lymphoma, vasculitis, granulomatosis with polyangiitis, microscopic polyangiitis, graft-versus-host disease, graft-versus-host disease following allogenic hematopoietic stem cell transplantation, graft-versus-host disease following keratoprosthesis, kidney transplant, asthma, chronic fatigue syndrome, major depression, and bipolar depression |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, August 25, 2016 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Amgen Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Thousand Oaks, CA 913201799 |
Party Name | Amgen Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Thousand Oaks, CA 913201799 |
Event Date | Event Description |
Tuesday, September 8, 2020 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Monday, September 7, 2020 | ABANDONMENT - NO USE STATEMENT FILED |
Saturday, November 23, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Friday, November 22, 2019 | EXTENSION 5 GRANTED |
Wednesday, November 20, 2019 | EXTENSION 5 FILED |
Friday, November 22, 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Wednesday, November 20, 2019 | TEAS EXTENSION RECEIVED |
Tuesday, May 28, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Friday, May 24, 2019 | EXTENSION 4 GRANTED |
Friday, May 24, 2019 | EXTENSION 4 FILED |
Friday, May 24, 2019 | TEAS EXTENSION RECEIVED |
Thursday, March 7, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Thursday, March 7, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Thursday, January 24, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, January 22, 2019 | EXTENSION 3 GRANTED |
Tuesday, January 22, 2019 | EXTENSION 3 FILED |
Tuesday, January 22, 2019 | TEAS EXTENSION RECEIVED |
Saturday, July 14, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Thursday, July 12, 2018 | EXTENSION 2 GRANTED |
Thursday, July 12, 2018 | EXTENSION 2 FILED |
Thursday, July 12, 2018 | TEAS EXTENSION RECEIVED |
Saturday, January 27, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Thursday, January 25, 2018 | EXTENSION 1 GRANTED |
Thursday, January 25, 2018 | EXTENSION 1 FILED |
Thursday, January 25, 2018 | TEAS EXTENSION RECEIVED |
Tuesday, August 1, 2017 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, June 6, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, June 6, 2017 | PUBLISHED FOR OPPOSITION |
Wednesday, May 17, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Wednesday, April 26, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, April 25, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, April 24, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, April 24, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, April 24, 2017 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Monday, October 31, 2016 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, October 31, 2016 | NON-FINAL ACTION E-MAILED |
Monday, October 31, 2016 | NON-FINAL ACTION WRITTEN |
Friday, October 28, 2016 | ASSIGNED TO EXAMINER |
Thursday, August 25, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Thursday, August 25, 2016 | NEW APPLICATION ENTERED IN TRAM |